|
Strides Pharma Science Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
6003.02 Cr.
|
P/BV
|
2.64
|
Book Value (Rs.)
|
246.48
|
|
52 Week High/Low (Rs.)
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
09/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.38
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 2288.62 | 2121.70 | 1929.42 | 1851.22 | 1837.17 |
| Total Income From Operations | 2288.62 | 2121.70 | 1929.42 | 1851.22 | 1837.17 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 813.06 | 728.96 | 612.15 | 576.30 | 865.38 |
| Purchase of Traded Goods | 134.77 | 163.31 | 120.14 | 116.25 | 71.62 |
| Increase/Decrease in Stocks | -29.47 | -54.80 | 70.75 | 75.65 | -78.31 |
| Employees Cost | 431.58 | 383.66 | 367.46 | 356.67 | 375.35 |
| Depreciation | 99.12 | 100.99 | 119.70 | 121.15 | 122.10 |
| Other Expenses | 485.88 | 477.03 | 439.20 | 454.45 | 444.85 |
| Total Expenses | 1934.95 | 1799.15 | 1729.40 | 1700.47 | 1800.99 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 353.67 | 322.56 | 200.02 | 150.75 | 36.18 |
| Other Income | 41.13 | -4.79 | 44.49 | 53.32 | 37.01 |
| P/L Before Interest, Excpt. Items & Tax | 394.80 | 317.77 | 244.52 | 204.07 | 73.19 |
| Interest | 162.54 | 159.44 | 155.01 | 138.96 | 122.18 |
| P/L Before Exceptional Items & Tax | 232.26 | 158.33 | 89.51 | 65.11 | -48.99 |
| Exceptional Items | -7.61 | -18.14 | -170.91 | 34.22 | -51.25 |
| P/L Before Tax | 224.65 | 140.19 | -81.40 | 99.33 | -100.25 |
| Tax | 38.06 | 29.35 | 2.24 | 11.18 | -66.48 |
| P/L After Tax from Ordinary Activities | 186.59 | 110.83 | -83.63 | 88.15 | -33.77 |
| Extra Ordinary Item | 0.00 | 54.22 | 0.00 | 0.00 | 18.57 |
| Net Profit/Loss For the Period | 186.59 | 165.05 | -83.63 | 88.15 | -15.20 |
| Minority Interest | 1.46 | 3.34 | 20.36 | 6.33 | 3.36 |
| Share Of P/L Of Associates | -24.61 | -100.55 | -75.18 | -184.05 | -101.23 |
| Net P/L After Minority Interest & Share Of Associates | 163.43 | 67.84 | -138.46 | -89.57 | -113.07 |
| | | | | | |
| Equity Share Capital | 91.96 | 91.90 | 90.30 | 90.30 | 90.29 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 17.78 | 17.96 | -15.33 | 9.76 | -12.58 |
| Diluted EPS (Rs.) | 17.75 | 0 | -15.33 | 0 | -12.58 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 17.78 | 17.96 | -15.33 | 9.76 | -12.58 |
| Diluted EPS (Rs.) | 17.75 | 0 | -15.33 | 0 | -12.58 |
| | | | | | |
| PBITOE Margin (%) | 15.45 | 15.20 | 10.36 | 8.14 | 1.96 |
| PBTE Margin (%) | 10.14 | 7.46 | 4.63 | 3.51 | -2.66 |
| PBT Margin (%) | 9.81 | 6.60 | -4.21 | 5.36 | -5.45 |
| PAT Margin (%) | 8.15 | 7.77 | -4.33 | 4.76 | -0.82 |
| PAT After MI And SOA Margin (%) | 7.14 | 3.19 | -7.17 | -4.83 | -6.15 |
